nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—CYP2A6—Methimazole—Graves' disease	0.272	0.302	CbGbCtD
Clozapine—CYP2E1—Methimazole—Graves' disease	0.179	0.199	CbGbCtD
Clozapine—CYP2C19—Methimazole—Graves' disease	0.112	0.125	CbGbCtD
Clozapine—CYP1A2—Methimazole—Graves' disease	0.104	0.115	CbGbCtD
Clozapine—CYP2C9—Methimazole—Graves' disease	0.0934	0.104	CbGbCtD
Clozapine—CYP2D6—Methimazole—Graves' disease	0.0854	0.0949	CbGbCtD
Clozapine—CYP3A4—Methimazole—Graves' disease	0.0543	0.0603	CbGbCtD
Clozapine—CALY—pituitary gland—Graves' disease	0.00289	0.0756	CbGeAlD
Clozapine—FMO3—eye—Graves' disease	0.00208	0.0544	CbGeAlD
Clozapine—CHRM5—eye—Graves' disease	0.00177	0.0462	CbGeAlD
Clozapine—Chlordiazepoxide—GABRA3—Graves' disease	0.00175	0.189	CrCbGaD
Clozapine—Clonazepam—GABRA3—Graves' disease	0.00169	0.183	CrCbGaD
Clozapine—Clorazepate—GABRA3—Graves' disease	0.00164	0.177	CrCbGaD
Clozapine—FMO3—pituitary gland—Graves' disease	0.00155	0.0404	CbGeAlD
Clozapine—FMO3—adipose tissue—Graves' disease	0.00154	0.0402	CbGeAlD
Clozapine—H1F0—connective tissue—Graves' disease	0.00147	0.0384	CbGeAlD
Clozapine—FMO3—thyroid gland—Graves' disease	0.00133	0.0348	CbGeAlD
Clozapine—Fludiazepam—GABRA3—Graves' disease	0.0012	0.13	CrCbGaD
Clozapine—HTR1D—eye—Graves' disease	0.00118	0.0309	CbGeAlD
Clozapine—HTR1D—connective tissue—Graves' disease	0.00114	0.0298	CbGeAlD
Clozapine—H1F0—pituitary gland—Graves' disease	0.00113	0.0296	CbGeAlD
Clozapine—H1F0—adipose tissue—Graves' disease	0.00113	0.0295	CbGeAlD
Clozapine—CYP2A6—adipose tissue—Graves' disease	0.00106	0.0276	CbGeAlD
Clozapine—Oxazepam—GABRA3—Graves' disease	0.00105	0.114	CrCbGaD
Clozapine—CYP1B1—eye—Graves' disease	0.00105	0.0274	CbGeAlD
Clozapine—Temazepam—GABRA3—Graves' disease	0.00104	0.113	CrCbGaD
Clozapine—CYP1B1—connective tissue—Graves' disease	0.00101	0.0264	CbGeAlD
Clozapine—H1F0—thyroid gland—Graves' disease	0.000977	0.0255	CbGeAlD
Clozapine—HTR7—connective tissue—Graves' disease	0.000908	0.0237	CbGeAlD
Clozapine—DRD2—eye—Graves' disease	0.000891	0.0233	CbGeAlD
Clozapine—Diazepam—GABRA3—Graves' disease	0.000865	0.0937	CrCbGaD
Clozapine—CYP1B1—pituitary gland—Graves' disease	0.000778	0.0203	CbGeAlD
Clozapine—CYP1B1—adipose tissue—Graves' disease	0.000775	0.0202	CbGeAlD
Clozapine—CHRM3—adipose tissue—Graves' disease	0.000732	0.0191	CbGeAlD
Clozapine—HRH1—eye—Graves' disease	0.000703	0.0184	CbGeAlD
Clozapine—HRH1—connective tissue—Graves' disease	0.000678	0.0177	CbGeAlD
Clozapine—ADRA1A—adipose tissue—Graves' disease	0.000672	0.0175	CbGeAlD
Clozapine—CYP1B1—thyroid gland—Graves' disease	0.000671	0.0175	CbGeAlD
Clozapine—ADRA2A—connective tissue—Graves' disease	0.000666	0.0174	CbGeAlD
Clozapine—DRD2—pituitary gland—Graves' disease	0.000661	0.0173	CbGeAlD
Clozapine—ADRA2C—pituitary gland—Graves' disease	0.000643	0.0168	CbGeAlD
Clozapine—ADRA2C—adipose tissue—Graves' disease	0.00064	0.0167	CbGeAlD
Clozapine—CHRM3—thyroid gland—Graves' disease	0.000633	0.0165	CbGeAlD
Clozapine—CYP2C8—pituitary gland—Graves' disease	0.000596	0.0156	CbGeAlD
Clozapine—HTR2A—eye—Graves' disease	0.000588	0.0153	CbGeAlD
Clozapine—HTR2A—connective tissue—Graves' disease	0.000566	0.0148	CbGeAlD
Clozapine—CYP1A1—adipose tissue—Graves' disease	0.000548	0.0143	CbGeAlD
Clozapine—HRH1—adipose tissue—Graves' disease	0.00052	0.0136	CbGeAlD
Clozapine—ADRA2A—pituitary gland—Graves' disease	0.000513	0.0134	CbGeAlD
Clozapine—ADRA2A—adipose tissue—Graves' disease	0.000511	0.0133	CbGeAlD
Clozapine—CYP1A2—thyroid gland—Graves' disease	0.000481	0.0126	CbGeAlD
Clozapine—CYP1A1—thyroid gland—Graves' disease	0.000474	0.0124	CbGeAlD
Clozapine—ADRA2A—thyroid gland—Graves' disease	0.000442	0.0115	CbGeAlD
Clozapine—HTR2A—pituitary gland—Graves' disease	0.000436	0.0114	CbGeAlD
Clozapine—CYP2E1—thyroid gland—Graves' disease	0.000433	0.0113	CbGeAlD
Clozapine—ABCB1—pituitary gland—Graves' disease	0.000286	0.00746	CbGeAlD
Clozapine—ABCB1—adipose tissue—Graves' disease	0.000285	0.00743	CbGeAlD
Clozapine—ABCB1—thyroid gland—Graves' disease	0.000246	0.00643	CbGeAlD
Clozapine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	5.88e-05	0.00111	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—GC—Graves' disease	5.83e-05	0.00111	CbGpPWpGaD
Clozapine—HRH4—GPCR downstream signaling—IL2RA—Graves' disease	5.79e-05	0.0011	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—TSHR—Graves' disease	5.72e-05	0.00109	CbGpPWpGaD
Clozapine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	5.71e-05	0.00108	CbGpPWpGaD
Clozapine—ABCB1—Allograft Rejection—IL1B—Graves' disease	5.7e-05	0.00108	CbGpPWpGaD
Clozapine—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	5.69e-05	0.00108	CbGpPWpGaD
Clozapine—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	5.62e-05	0.00107	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—TSHR—Graves' disease	5.48e-05	0.00104	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—TSHR—Graves' disease	5.45e-05	0.00103	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—TSHR—Graves' disease	5.38e-05	0.00102	CbGpPWpGaD
Clozapine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	5.35e-05	0.00101	CbGpPWpGaD
Clozapine—HRH4—Signaling by GPCR—IL2RA—Graves' disease	5.26e-05	0.000998	CbGpPWpGaD
Clozapine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.26e-05	0.000998	CbGpPWpGaD
Clozapine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	5.19e-05	0.000984	CbGpPWpGaD
Clozapine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	5.16e-05	0.00098	CbGpPWpGaD
Clozapine—CHRM2—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.16e-05	0.00098	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.14e-05	0.000975	CbGpPWpGaD
Clozapine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	5.14e-05	0.000975	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—GC—Graves' disease	5.11e-05	0.000969	CbGpPWpGaD
Clozapine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	5.1e-05	0.000968	CbGpPWpGaD
Clozapine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	5.09e-05	0.000966	CbGpPWpGaD
Clozapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	5.09e-05	0.000966	CbGpPWpGaD
Clozapine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	5.09e-05	0.000966	CbGpPWpGaD
Clozapine—CHRM1—GPCR ligand binding—CXCL10—Graves' disease	5.07e-05	0.000963	CbGpPWpGaD
Clozapine—CHRM3—GPCR ligand binding—CXCL10—Graves' disease	5.06e-05	0.00096	CbGpPWpGaD
Clozapine—HTR1E—GPCR downstream signaling—IL2RA—Graves' disease	5.04e-05	0.000957	CbGpPWpGaD
Clozapine—CHRM2—GPCR ligand binding—CXCL10—Graves' disease	5.01e-05	0.00095	CbGpPWpGaD
Clozapine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	5e-05	0.000948	CbGpPWpGaD
Clozapine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	5e-05	0.000948	CbGpPWpGaD
Clozapine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	4.99e-05	0.000946	CbGpPWpGaD
Clozapine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	4.92e-05	0.000933	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	4.86e-05	0.000922	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—GC—Graves' disease	4.82e-05	0.000914	CbGpPWpGaD
Clozapine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	4.81e-05	0.000913	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	4.69e-05	0.00089	CbGpPWpGaD
Clozapine—HRH3—Signaling Pathways—CXCL10—Graves' disease	4.67e-05	0.000886	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	4.67e-05	0.000885	CbGpPWpGaD
Clozapine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	4.64e-05	0.000881	CbGpPWpGaD
Clozapine—HTR1E—Signaling by GPCR—IL2RA—Graves' disease	4.58e-05	0.000869	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	4.54e-05	0.000861	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	4.53e-05	0.00086	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—GC—Graves' disease	4.52e-05	0.000857	CbGpPWpGaD
Clozapine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	4.51e-05	0.000855	CbGpPWpGaD
Clozapine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	4.5e-05	0.000854	CbGpPWpGaD
Clozapine—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	4.47e-05	0.000849	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	4.47e-05	0.000847	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	4.46e-05	0.000846	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	4.45e-05	0.000845	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—TSHR—Graves' disease	4.44e-05	0.000842	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—TSHR—Graves' disease	4.42e-05	0.000839	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—B3GNT2—Graves' disease	4.42e-05	0.000838	CbGpPWpGaD
Clozapine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	4.42e-05	0.000838	CbGpPWpGaD
Clozapine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	4.38e-05	0.000831	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—TSHR—Graves' disease	4.38e-05	0.000831	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	4.37e-05	0.000829	CbGpPWpGaD
Clozapine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	4.31e-05	0.000818	CbGpPWpGaD
Clozapine—CHRM4—GPCR downstream signaling—CXCL10—Graves' disease	4.25e-05	0.000807	CbGpPWpGaD
Clozapine—ADRA2B—Hemostasis—IL2RA—Graves' disease	4.18e-05	0.000793	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—GC—Graves' disease	4.15e-05	0.000787	CbGpPWpGaD
Clozapine—ABCB1—Allograft Rejection—TNF—Graves' disease	4.14e-05	0.000785	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—TSHR—Graves' disease	4.12e-05	0.000781	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	4.09e-05	0.000777	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	4.09e-05	0.000776	CbGpPWpGaD
Clozapine—CHRM5—GPCR downstream signaling—CXCL10—Graves' disease	4.07e-05	0.000773	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—CXCL10—Graves' disease	4.07e-05	0.000772	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	4.06e-05	0.000771	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	4.06e-05	0.00077	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	4.05e-05	0.000769	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—TSHR—Graves' disease	4.04e-05	0.000767	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—TSHR—Graves' disease	4.03e-05	0.000765	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—TSHR—Graves' disease	4.02e-05	0.000762	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	3.98e-05	0.000755	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—TSHR—Graves' disease	3.98e-05	0.000755	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	3.97e-05	0.000753	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	3.91e-05	0.000743	CbGpPWpGaD
Clozapine—ADRA2C—Hemostasis—IL2RA—Graves' disease	3.91e-05	0.000741	CbGpPWpGaD
Clozapine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	3.88e-05	0.000736	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—B3GNT2—Graves' disease	3.87e-05	0.000734	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—CXCL10—Graves' disease	3.86e-05	0.000733	CbGpPWpGaD
Clozapine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	3.83e-05	0.000726	CbGpPWpGaD
Clozapine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	3.82e-05	0.000724	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—GC—Graves' disease	3.81e-05	0.000722	CbGpPWpGaD
Clozapine—CHRM2—SIDS Susceptibility Pathways—TNF—Graves' disease	3.75e-05	0.000711	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—TSHR—Graves' disease	3.74e-05	0.00071	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—TSHR—Graves' disease	3.74e-05	0.000709	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—TSHR—Graves' disease	3.71e-05	0.000705	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—CXCL10—Graves' disease	3.7e-05	0.000702	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	3.69e-05	0.000699	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—B3GNT2—Graves' disease	3.65e-05	0.000693	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—TSHR—Graves' disease	3.64e-05	0.00069	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—GC—Graves' disease	3.59e-05	0.000681	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—TSHR—Graves' disease	3.58e-05	0.000679	CbGpPWpGaD
Clozapine—HRH3—Signaling Pathways—IL2RA—Graves' disease	3.57e-05	0.000677	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—CXCL10—Graves' disease	3.54e-05	0.000672	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—TSHR—Graves' disease	3.53e-05	0.00067	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	3.52e-05	0.000669	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	3.48e-05	0.00066	CbGpPWpGaD
Clozapine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	3.46e-05	0.000656	CbGpPWpGaD
Clozapine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	3.45e-05	0.000654	CbGpPWpGaD
Clozapine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	3.44e-05	0.000653	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—B3GNT2—Graves' disease	3.43e-05	0.00065	CbGpPWpGaD
Clozapine—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	3.42e-05	0.000649	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—TSHR—Graves' disease	3.38e-05	0.000641	CbGpPWpGaD
Clozapine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	3.35e-05	0.000635	CbGpPWpGaD
Clozapine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	3.34e-05	0.000633	CbGpPWpGaD
Clozapine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	3.32e-05	0.00063	CbGpPWpGaD
Clozapine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	3.3e-05	0.000625	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—GC—Graves' disease	3.29e-05	0.000624	CbGpPWpGaD
Clozapine—CHRM4—GPCR downstream signaling—IL2RA—Graves' disease	3.25e-05	0.000617	CbGpPWpGaD
Clozapine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	3.23e-05	0.000613	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—TSHR—Graves' disease	3.22e-05	0.000611	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—TSHR—Graves' disease	3.18e-05	0.000603	CbGpPWpGaD
Clozapine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	3.18e-05	0.000603	CbGpPWpGaD
Clozapine—ADRA2A—Hemostasis—IL2RA—Graves' disease	3.17e-05	0.000602	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—B3GNT2—Graves' disease	3.14e-05	0.000596	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	3.14e-05	0.000596	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	3.13e-05	0.000594	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	3.13e-05	0.000593	CbGpPWpGaD
Clozapine—CHRM5—GPCR downstream signaling—IL2RA—Graves' disease	3.11e-05	0.000591	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—IL2RA—Graves' disease	3.11e-05	0.00059	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	3.11e-05	0.000589	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	3.04e-05	0.000577	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	3.03e-05	0.000575	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	3.02e-05	0.000572	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	2.99e-05	0.000568	CbGpPWpGaD
Clozapine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	2.97e-05	0.000563	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—IL2RA—Graves' disease	2.95e-05	0.00056	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—GC—Graves' disease	2.94e-05	0.000557	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	2.93e-05	0.000556	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	2.93e-05	0.000556	CbGpPWpGaD
Clozapine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	2.93e-05	0.000555	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	2.89e-05	0.000548	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—B3GNT2—Graves' disease	2.89e-05	0.000547	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	2.88e-05	0.000547	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	2.88e-05	0.000546	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	2.87e-05	0.000544	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—CXCL10—Graves' disease	2.87e-05	0.000544	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—GC—Graves' disease	2.87e-05	0.000544	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—CXCL10—Graves' disease	2.86e-05	0.000542	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—CXCL10—Graves' disease	2.83e-05	0.000537	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—IL2RA—Graves' disease	2.83e-05	0.000536	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	2.82e-05	0.000536	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—TSHR—Graves' disease	2.77e-05	0.000526	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—TSHR—Graves' disease	2.76e-05	0.000523	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—B3GNT2—Graves' disease	2.72e-05	0.000516	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—IL2RA—Graves' disease	2.71e-05	0.000513	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—GC—Graves' disease	2.7e-05	0.000513	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	2.69e-05	0.000511	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	2.68e-05	0.000509	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—GC—Graves' disease	2.68e-05	0.000508	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	2.66e-05	0.000505	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	2.66e-05	0.000504	CbGpPWpGaD
Clozapine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	2.64e-05	0.000501	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	2.64e-05	0.000501	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	2.62e-05	0.000498	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	2.62e-05	0.000497	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	2.61e-05	0.000496	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—CXCL10—Graves' disease	2.6e-05	0.000494	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—CXCL10—Graves' disease	2.6e-05	0.000492	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—CXCL10—Graves' disease	2.57e-05	0.000488	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	2.56e-05	0.000486	CbGpPWpGaD
Clozapine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	2.55e-05	0.000484	CbGpPWpGaD
Clozapine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	2.54e-05	0.000481	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—B3GNT2—Graves' disease	2.49e-05	0.000473	CbGpPWpGaD
Clozapine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	2.47e-05	0.000468	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—TSHR—Graves' disease	2.43e-05	0.000461	CbGpPWpGaD
Clozapine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	2.43e-05	0.000461	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—CXCL10—Graves' disease	2.42e-05	0.000459	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—CXCL10—Graves' disease	2.42e-05	0.000458	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—CXCL10—Graves' disease	2.4e-05	0.000455	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	2.4e-05	0.000455	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—TSHR—Graves' disease	2.39e-05	0.000454	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—TSHR—Graves' disease	2.39e-05	0.000453	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	2.38e-05	0.000452	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—TSHR—Graves' disease	2.38e-05	0.000452	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—TSHR—Graves' disease	2.37e-05	0.00045	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	2.35e-05	0.000446	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—TSHR—Graves' disease	2.35e-05	0.000446	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	2.34e-05	0.000445	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	2.32e-05	0.000439	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—CXCL10—Graves' disease	2.31e-05	0.000439	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	2.3e-05	0.000437	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—GC—Graves' disease	2.29e-05	0.000434	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—CXCL10—Graves' disease	2.28e-05	0.000433	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	2.24e-05	0.000425	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	2.24e-05	0.000425	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.23e-05	0.000422	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	2.21e-05	0.000418	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	2.2e-05	0.000418	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	2.2e-05	0.000417	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—IL2RA—Graves' disease	2.19e-05	0.000416	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—CXCL10—Graves' disease	2.18e-05	0.000414	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—IL2RA—Graves' disease	2.18e-05	0.000414	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	2.18e-05	0.000413	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—B3GNT2—Graves' disease	2.17e-05	0.000412	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—IL2RA—Graves' disease	2.16e-05	0.00041	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	2.16e-05	0.000409	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—CXCL10—Graves' disease	2.08e-05	0.000395	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—CXCL10—Graves' disease	2.05e-05	0.00039	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—B3GNT2—Graves' disease	2.05e-05	0.000389	CbGpPWpGaD
Clozapine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.04e-05	0.000387	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	2.03e-05	0.000386	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—B3GNT2—Graves' disease	2.03e-05	0.000385	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	2e-05	0.00038	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	2e-05	0.00038	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	2e-05	0.000379	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—IL2RA—Graves' disease	1.99e-05	0.000378	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—IL2RA—Graves' disease	1.98e-05	0.000376	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—IL2RA—Graves' disease	1.96e-05	0.000373	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	1.96e-05	0.000372	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	1.85e-05	0.000352	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—IL2RA—Graves' disease	1.85e-05	0.000351	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—IL2RA—Graves' disease	1.85e-05	0.00035	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—IL2RA—Graves' disease	1.83e-05	0.000348	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	1.82e-05	0.000345	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	1.8e-05	0.000341	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	1.79e-05	0.00034	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	1.78e-05	0.000338	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—IL2RA—Graves' disease	1.77e-05	0.000335	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—GC—Graves' disease	1.77e-05	0.000335	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—IL2RA—Graves' disease	1.74e-05	0.000331	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—B3GNT2—Graves' disease	1.73e-05	0.000329	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	1.73e-05	0.000329	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	1.7e-05	0.000323	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—IL2RA—Graves' disease	1.67e-05	0.000317	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—IL2RA—Graves' disease	1.59e-05	0.000302	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CXCL10—Graves' disease	1.57e-05	0.000298	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—IL2RA—Graves' disease	1.57e-05	0.000298	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	1.55e-05	0.000293	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CXCL10—Graves' disease	1.54e-05	0.000293	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CXCL10—Graves' disease	1.54e-05	0.000292	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CXCL10—Graves' disease	1.53e-05	0.000291	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CXCL10—Graves' disease	1.52e-05	0.000288	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	1.51e-05	0.000287	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	1.42e-05	0.000269	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	1.41e-05	0.000267	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	1.37e-05	0.00026	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	1.36e-05	0.000258	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.34e-05	0.000254	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	1.32e-05	0.000251	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	1.3e-05	0.000247	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IL2RA—Graves' disease	1.2e-05	0.000228	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	1.18e-05	0.000224	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IL2RA—Graves' disease	1.18e-05	0.000224	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IL2RA—Graves' disease	1.18e-05	0.000223	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IL2RA—Graves' disease	1.17e-05	0.000222	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IL2RA—Graves' disease	1.16e-05	0.00022	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	1.16e-05	0.00022	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	1.08e-05	0.000204	CbGpPWpGaD
